Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Adenocarcinoma × Leucovorin × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 53 Colonic Neoplasms 29 Rectal Neoplasms 27 Stomach Neoplasms 14 Pancreatic Neoplasms 13 Neoplasm Metastasis 13 Carcinoma, Hepatocellular 13 Esophageal Neoplasms 5 Leukemia 4 Neoplasms 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Solid Tumors 2 Neutropenia 2 Lymphoma 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Digestive System Neoplasms 2 Colorectal Cancer Metastatic 2 Carcinoma 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2 Bile Duct Neoplasms 2 Adenocarcinoma Of Esophagus 2 mCRC 1 Unresectable Sinonasal Tumors 1 Thymoma 1 Sinonasal Tumors 1 Resected Liver Metastases From Colorectal Cancer 1 Previously Treated Metastatic Colorectal Cancer 1

Interventions

irinotecan sucrosofate 1 folfirinox 1 Taxes 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiosurgery 1 Oxaliplatin 1 Leucovorin 1 Gemcitabine 1 Folfox protocol 1 Fluorouracil 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡